ESTRO 2025 - Abstract Book

S1586

Clinical – Mixed sites & palliation

ESTRO 2025

relative to their remaining lifespan is shown in Figure e. Overall, 44% of the patients spent between 40-100% of their final days receiving radiotherapy.